drugset / Trial / NCT00419692

Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food

NCT00419692

Phase 1 Completed 32 enrolled GlaxoSmithKline
RandomizedCrossoverOpen-labelTreatment

Summary

This study in RLS patients is designed to assess the affect food has on the absorption, distribution, metabolism and excretion of ropinirole (by dosing some patients in the fasted state and other patients following a high-fat breakfast), and to assess the difference in absorption, distribution, metabolism and excretion of ropinirole if patients are given two 3mg ropinirole tablets versus one 6mg tablet.

Timeline

Start
2006-08-24
Primary completion
2006-12-12
Completion
2006-12-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropinirole Small molecule 6 mg